# Mirabegron

## BETMIGA 50mg prolonged-release

##### 

| 藥品代碼   | OBET5                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Neurogenic detrusor overactivity. Overactive bladder， Monotherapy or in combination with solifenacin， with symptoms of urge urinary incontinence， urgency， and urinary frequency.                                                                                                                                                                                                                                                          |
| 用法用量   | 25-50 mg once daily. May be taken with or without food. Swallow whole， do not chew， divide or crush.                                                                                                                                                                                                                                                                                                                                         |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常 | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 禁忌       | Hypersensitivity to mirabegron or any components of the product.                                                                                                                                                                                                                                                                                                                                                                               |
| 副作用     | Common Cardiovascular: Hypertension (7% to 11.3% )， Tachycardia (1.2% to 2.2% ) Gastrointestinal: Constipation (1.2% to 4.7% )， Xerostomia (2.8% to 9.3% ) Neurologic: Headache (1.6% to 4.1% ) Renal: Urinary tract infectious disease (Adult， 2.9% to 8.4% ; pediatric， 24.4% ) Respiratory: Nasopharyngitis (3.5% to 5.8% ) Serious Neurologic: Cerebrovascular accident (0.4% ) Renal: Urinary retention Other: Cancer (0.1% to 1.3% ) |
| 孕期建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                           |

